References
- Fraser C G, Harris E K. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409–37
- Holzel WGE. Intra-individual variation of analytes in serum in patients with insulin-dependent diabetes mellitus. Clin Chem 1987; 33: 57–61
- Holzel WGE. Intra-individual variation of analytes in serum in patients with chronic renal failure. Clin Chem 1987; 33: 670–673
- Browning MCK, McFarlane N F. Objective interpretation of results of tumour markers. J Nucl Med Allied Sci 1990; 89–91, Suppl 1
- Soletormos G, Schioler V, Nielsen D, Skovsgaard T, Dombemowsky P. Interpretation of results for tumour marker on the basis of analytical imprecision and biological variation. Clin Chem 1993; 39: 2077–2083
- Gion M, Cappelli G, Mione R, Vignati G, Fortunato A, Saracchini S, Biasoli R, Gulisano M. Variability of tumour markers in the follow-up of patients radically resected for breast cancer. Tumour Biol 1993; 14: 325–333
- Harris E K. Statistical principles underlying analytic goal-setting in clinical chemistry. Am J Clin Pathol 1979; 72: 374–82
- Winkel P, Weis Bentzon M, Statland B E, Mouridson H, Sheike O. Predicting recurrence in patients with breast cancer from cumulative laboratory results:a new technique for the application of time series analysis. Clin Chem 1982; 28: 2057–679
- Tondini C, Hayes D F, Gelman R, Craig Henderson I, Kufe D W. Comparison of CA 15—3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res 1988; 45: 4107–12
- Dniastrian A M, Schwartz M K, Greenberg E J, Smith C A, Schwartz D C. CA 15—3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. Clin Chim Acta 1991; 200: 81–94
- Fraser C G, Hyltoft Petersen P, Ricos C, Haeckel R. Proposed quality specifications for the imprecision and inaccuracy of analytical systems for clinical chemistry. Eur J Clin Chem Clin Biochem 1992; 30: 811–17
- Hölzel WGE. Analytical variation in immunoassays and its importance for medical decision-making. Scand J Clin Lab Invest 1991; 51: 113–119, Suppl 205
- Jäger W. Scand J Clin Lab Invest 1995; 51: 87–92, Suppl 221
- O'Brien D P, Horgan P G, Gough D B, Skehill R, Grimes H, Given H F. CA 15—3:a reliable indicator of metastatic bone disease in breast cancer patients. Ann R Coll Surg Engl 1992; 74: 9–12